ASND Price Prediction Next Week
Stock Price Prediction and Recommendation for ASND
Based on the analysis of technical indicators and recent news sentiment:
Technical Analysis:
- RSI (14): 38.21, indicating oversold conditions and potential buy signal.
- MACD: Positive but showing bearish divergence, suggesting short-term weakness.
- Fibonacci Levels:
- Pivot: $151.61
- Resistance 1: $156.67
- Support 1: $146.55
News Sentiment:
- Strong analyst consensus with a Strong Buy rating and price targets ranging from $196 to $225.
- Recent financial performance shows improving revenue and significant upfront payments, though the stock has faced selling pressure.
Price Prediction:
The stock is expected to reach $156 in the next trading week, with potential resistance at this level.
Recommendation:
Sell at $156 to lock in profits, as technical indicators suggest a potential pullback after reaching this target.
ASND Similar Chart Price Prediction
The price of ASND is predicted to go up -55.19%, based on the high correlation periods with ADNT. The similarity of these two price pattern on the periods is 98.14%.
ASND
ADNT
Down: -55.19%Similarity: 98.14%
ASND Revenue Forecast
ASND EPS Forecast
ASND FAQs
What is ASND revenue forecast for next quarter？
What is ASND eps forecast for next quarter？
ASND Analyst's Forecast
Eliana Merle
UBS
Strong Buy
2025-01-07
Price Target
$196
Upside
+42.91%
UBS analyst Eliana Merle initiated coverage of Ascendis Pharma with a Buy rating and $196 price target. UBS thinks the next 1-3 years could be "transformative" for Ascendis shares with multiple launches and a likely turn to profitability, the analyst tells investors in a research note. The firm sees growth ahead from the Yorvipath launch and the potential for upside surprises, and feels the central nervous system opportunity is underappreciated long-term.
Yaron Werber
TD Cowen
Strong Buy
2024-11-15
Price Target
$160 → $153
Upside
+19.21%
Jessica Fye
JP Morgan
Buy
2024-10-23
Price Target
$180 → $174
Upside
+36.27%
